Novartis (NVS) Insider Trading & Ownership $126.40 -0.07 (-0.05%) Closing price 03:59 PM EasternExtended Trading$126.50 +0.09 (+0.08%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock There is no recent insider trading on record for Novartis, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public. Get NVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Novartis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Novartis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction7/22/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$117.00$1,001 - $15,0006/17/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$116.37$1,001 - $15,0006/11/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$117.99$1,001 - $15,0006/10/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$118.59$1,001 - $15,0006/9/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$118.01$1,001 - $15,0003/24/2025George WhitesidesU.S. Congress Member (D-CA)Sell$111.14$100,001 - $250,0004/9/2024Sheldon WhitehouseU.S. Congress Member (D-RI)Sell$95.80$1,001 - $15,0009/20/2023Sheldon WhitehouseU.S. Congress Member (D-RI)Buy$103.58$15,001 - $50,0007/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$96.55$50,001 - $100,0004/26/2023Thomas R. CarperU.S. Congress Member (D-DE)Buy$102.54$1,001 - $15,0003/31/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$92.00$50,001 - $100,0002/27/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$85.55$15,001 - $50,0001/31/2023Kevin HernU.S. Congress Member (R-OK)Sell$90.62$1,001 - $15,000 (Data available from 1/1/2013 forward) NVS Insider Trading Activity - Frequently Asked Questions What percentage of Novartis stock is owned by insiders? 0.01% of Novartis stock is owned by insiders. Learn more on NVS's insider holdings. Which members of congress are trading Novartis? Lisa C. McClain (R-MI) has bought shares of Novartis in the last year totaling $24,000. Lisa C. McClain (R-MI) and George Whitesides (D-CA) have sold shares totaling $191,000. Novartis Key ExecutivesDr. Vasant Narasimhan M.D. (Age 48)Chief Executive Officer Compensation: $8.01MMr. Harry Kirsch (Age 59)Chief Financial Officer Compensation: $3.99MMr. Victor Bulto (Age 46)President of US Compensation: $3.28MDr. Patrick Horber M.D. (Age 54)President of International Compensation: $7.31MDr. Steffen Lang Ph.D. (Age 57)President of Operations Compensation: $2.34MPaul PenepentHead of Group Financial Reporting and AccountingMs. Sloan SimpsonGlobal Head of Investor RelationsDr. Klaus Moosmayer Ph.D. (Age 56)Chief Ethics, Risk & Compliance Officer Compensation: $1.55MMs. Karen L. Hale (Age 56)Chief Legal Officer Compensation: $2.34MDr. Robert Kowalski Pharm.D. (Age 56)Chief People & Organization Officer Compensation: $2.1M More Insider Trading Tools from MarketBeat Related Companies AZN Insider Trades NVO Insider Trades SNY Insider Trades GSK Insider Trades TAK Insider Trades ARGX Insider Trades ONC Insider Trades INSM Insider Trades BNTX Insider Trades TEVA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NYSE:NVS) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Novartis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access